Severe Asthma Clinical Trial
Official title:
The Russian Registry of Patients With Severe Asthma to Collect Anonymous Long-term Evidence
The Russian Severe Asthma Registry is a Russian initiative to collect anonymous long-term evidence for patients with severe asthma in Russia
The Russian Severe Asthma Registry is a Russian initiative to collect anonymous long-term
evidence for patients with severe asthma in Russia. The RSAR initiative is realized under the
efforts of the Interregional Public Organization "Russian Respiratory Society" and LLC "RSMI"
with the sponsorship of "AstraZeneca Pharmaceuticals" LLC.
The developed RSAR electronic database is a Russian software product that meets the current
requirements of the Russian legislation in the field of working with personal data and the
implementation of similar observational studies.
Participating researchers also agree to grant access and share anonymous data at the patient
level as part of the work to implement the RSAR initiative. Participants will provide
high-quality data for the development of data sets for research, approved by the Russian
Respiratory Society (RPO), which has priority in owning and implementation in scientific
field of the gained data. Based on ethical, legal and regulatory authorizations, anonymous
data will be collected in the Central Database (CDB) on respiratory diseases (referred to
here as the RSAR database) to create sets of important data and the necessary analysis. CDB
is part of the software "Medical online platform ROSMED.INFO".
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05018299 -
Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma
|
Phase 2 | |
Recruiting |
NCT05472324 -
Evaluate the Efficacy and Safety of TQC2731 Injection in Patients With Severe Asthma.
|
Phase 2 | |
Recruiting |
NCT04914078 -
Severe Asthma Exacerbations and Mepolizumab Treatment
|
||
Completed |
NCT05576454 -
Evaluate the Pharmacokinetics of BAT2606 Injection in Healthy Chinese Male Subjects
|
Phase 1 | |
Recruiting |
NCT04438408 -
National Survey on Care Pathway and Quality of Life in Patients With Severe Asthma According to Their Phenotype.
|
||
Recruiting |
NCT04520165 -
Effect of Biologicals on Alternative Functions of Eosinophils in Severe Asthma
|
||
Not yet recruiting |
NCT04463836 -
Phenotyping Circulating and Lung Resident Eosinophils in Severe Asthma (P-CLESA)
|
||
Recruiting |
NCT03377920 -
Predictive Value of Spirometric PIF to Produce PIF Rate Needed for the Use of Current DPI's.
|
N/A | |
Recruiting |
NCT04565483 -
Predictive Signature of Benralizumab Response
|
Phase 4 | |
Recruiting |
NCT04045587 -
International Severe Asthma Registry: Canadian Cohort
|
||
Completed |
NCT05616338 -
Modeling Bronchial Epithelium in Severe Asthma With Human Induced Pluripotent Stem Cells (iPSC)
|
N/A | |
Active, not recruiting |
NCT02038374 -
Clinico-biological Correlation of Severe Asthma in Children
|
N/A | |
Active, not recruiting |
NCT02114034 -
Cohort Analysis of Clinical and Biological Severe Childhood Asthma
|
||
Recruiting |
NCT06035289 -
Register Schweres Asthma - German Asthma Net e.V.
|
||
Not yet recruiting |
NCT03532685 -
Clinical, Inflammatory and Functional Evaluation of a Population of Severe and Obese Asthmatics: Follow up
|
N/A | |
Completed |
NCT03931954 -
Prevalence of the Eosinophilic Phenotype Among Severe Asthma Patients
|
||
Recruiting |
NCT03984253 -
Swiss Severe Asthma Register
|
||
Recruiting |
NCT03435237 -
Phenotyping Asthma for Bronchial Thermoplasty
|
||
Recruiting |
NCT03476109 -
Study of Magnitude and Prediction of Response to Omalizumab and Mepolizumab in Adult Severe Asthma.
|
Phase 4 | |
Recruiting |
NCT04714567 -
Portuguese Severe Asthma Registry: Getting Answers for Severe Asthma Patients
|